The effectiveness and value of eculizumab and efgartigimod for generalized myasthenia gravis

被引：0
作者：
Tice, Jeffrey A. [1 ]
Touchette, Daniel R. [2 ]
Lien, Pei-Wen [2 ]
Agboola, Foluso [3 ]
Nikitin, Dmitriy [3 ]
Pearson, Steven D. [3 ]
机构：
[1] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA
[2] Univ Illinois, Coll Pharm, Chicago, IL USA
[3] ICER, Boston, MA USA
来源：
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY | 2022年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：119 / 124
页数：6
相关论文
共 11 条
  • [1] A systematic review of population based epidemiological studies in Myasthenia Gravis
    Carr, Aisling S.
    Cardwell, Chris R.
    McCarron, Peter O.
    McConville, John
    [J]. BMC NEUROLOGY, 2010, 10
  • [2] Myasthenia Gravis
    Gilhus, Nils E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (26) : 2570 - 2581
  • [3] Myasthenia gravis: subgroup classification and therapeutic strategies
    Gilhus, Nils Erik
    Verschuuren, Jan J.
    [J]. LANCET NEUROLOGY, 2015, 14 (10) : 1023 - 1036
  • [4] Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study
    Hendricks, Tina M.
    Bhatti, M. Tariq
    Hodge, David O.
    Chen, John J.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 205 : 99 - 105
  • [5] Howard J, 2015, Myasthenia gravis clinical overview
  • [6] Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT) : a multicentre, randomised, placebo-controlled, phase 3 trial
    Howard, James F. Jr Jr
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Perk, Stojan
    Margania, Temur
    Murai, Hiroyuki
    Bilinska, Malgorzata
    Shakarishvili, Roman
    Smilowski, Marek
    Guglietta, Antonio
    Ulrichts, Peter
    Vangeneugden, Tony
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    [J]. LANCET NEUROLOGY, 2021, 20 (07) : 526 - 536
  • [7] Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
    Mantegazza, Renato
    Wolfe, Gil, I
    Muppidi, Srikanth
    Wiendl, Heinz
    Fujita, Kenji P.
    O'Brien, Fanny L.
    Booth, Heather D. E.
    Howard, James F., Jr.
    [J]. NEUROLOGY, 2021, 96 (04) : E610 - E618
  • [8] International Consensus Guidance for Management of Myasthenia Gravis 2020 Update
    Narayanaswami, Pushpa
    Sanders, Donald B.
    Wolfe, Gil
    Benatar, Michael
    Cea, Gabriel
    Evoli, Amelia
    Gilhus, Nils Erik
    Illa, Isabel
    Kuntz, Nancy L.
    Massey, Janice
    Melms, Arthur
    Murai, Hiroyuki
    Nicolle, Michael
    Palace, Jacqueline
    Richman, David
    Verschuuren, Jan
    [J]. NEUROLOGY, 2021, 96 (03) : 114 - 122
  • [9] Phillips G, 2020, ICER MYATHENIA GRAVI, P6
  • [10] The Motley Fool, 2020, ARG SE ARGX Q3 2020
12